Summer of anterior segment and CLs
The Cornea and Contact Lens Society (CCLS) 2026 conference – themed Eyeland Vibes – is being held 12–14 February at Trinity Wharf in Tauranga.
Staff reporters1 min read
Ophthalmology News
Global blindness burden to rise by 2050
Researchers analysing Global Burden of Disease Study 2021 data reported blindness-related burden will continue to increase as populations age. The analysis, published in The Lancet Global Health, asse
Staff reporters1 min read
Celia the bus taking equity to the school gate
New Zealand’s first dedicated school vision bus, Celia, is set to launch within weeks, bringing free eye exams to children who would otherwise go without.
Susie Hill4 min read
Salivary gland transplant for DED
Minor salivary gland transplantation (MSGT) is a promising surgical option for patients with severe dry eye disease (DED) where tear production is absent, especially for those with Stevens-Johnson syndrome, according to US ophthalmologists.
Staff reporters1 min read
ISBCS shown to be safe and effective
Two studies presented at the recent 43rd Congress of the European Society of Cataract and Refractive Surgeons found immediate sequential bilateral cataract surgery (ISBCS) to be safe, practical and often associated with better visual outcomes than delayed sequential bilateral cataract surgery (DSBCS
Staff reporters2 min read
NZ survey exposes gaps in scleral shell care
Researchers at the University of Auckland found “significant inconsistencies” in the way clinicians manage patients with blind disfigured eyes, specifically regarding the provision and care of custom scleral-shell prostheses.
Staff reporters2 min read
Insights into patients’ presbyopic lives
A recent survey for Johnson & Johnson Vision uncovered a significant gap in how middle-aged Australians understand and manage presbyopia. It found the condition is often overlooked or under-treated, p
Staff reporters2 min read
Weight-loss drugs linked to lower uveitis risk
US researchers found patients prescribed glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as Ozempic and Wegovy, had about half the risk of developing non-infectious uveitis compared with ma
Staff reporters1 min read
Norway launches AI screening for DR
Norway is incorporating AI-powered eye screening in its national health system to address ophthalmologist shortages and reduce preventable blindness from diabetes. Partnering with Eyenuk, a US-
Staff reporters1 min read
Research grants target eye health equity
Five new projects funded by the Australian and New Zealand Eye Foundation (ANZEF, the philanthropic arm of RANZCO) will investigate eye-health inequities across New Zealand and the Pacific, focusing on screening, service access, treatment participation and clinical trial inclusion.
Staff reporters3 min read
Vabysmo funding potential causes submission flurry
A Pharmac proposal to fund four new medicines from Roche, including the anti-VEGF treatment Vabysmo (faricimab) for neovascular (wet) age-related macular degeneration (nAMD) and diabetic macular oedema (DMO), resulted in several hastily despatched submissions from the eyecare industry.
Lesley Springall5 min read
Poor eyedrop technique revealed
Researchers at China’s Fudan University found almost two-thirds of glaucoma patients struggle to instil eye drops correctly, with self-reported confidence often not matching observed technique. P
Staff reporters1 min read